Skip to content

Oruka Therapeutics, Inc. ORKA Total Current Assets

Total Current Assets at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$27.21B-11.6%
Eli Lilly logo
Eli LillyLLY
$54.84B+32.9%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$59.17B-17.3%
Amgen logo
AmgenAMGN
$31.48B+16.9%
AbbVie logo
AbbVieABBV
$33.53B+21.2%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$677.43M+35.2%

Other financials

Income statement

See full
Revenue-
Operating income-$36.4M-45.2%
Net income-$31.8M-51.5%
EPS (diluted)-$0.46+93.4%

Balance sheet

See full
Cash & equivalents$49.5M-40.7%
Total debt$1.8M+90.8%
Total equity$486.7M+33.4%
Total assets$504.5M+33.8%

Cash flow

See full
Operating cash flow-$23.6M-13.0%
CapEx$73.0K+462%
Free cash flow-$23.7M-13.3%

Valuation

See full
Market cap$4.36B+533%
Enterprise value$4.32B+690%

Returns & leverage

See full
Return on equity-27.3%-11.1pp
Debt / equity0.0×
Current ratio23.8×-6.3×

Where this comes from

Reported directly by Oruka Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Oruka Therapeutics, Inc.'s total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Oruka Therapeutics, Inc.'s total current assets?
Oruka Therapeutics, Inc. (ORKA) reported total current assets of $395.25M in Q1 2026.
How has Oruka Therapeutics, Inc.'s total current assets changed year-over-year?
Oruka Therapeutics, Inc.'s total current assets increased by 12.3% year-over-year, from $352.08M to $395.25M.
What is the long-term trend for Oruka Therapeutics, Inc.'s total current assets?
Over 5 years (2020 to 2025), Oruka Therapeutics, Inc.'s total current assets has grown at a 47.1% compound annual growth rate (CAGR), from $49.97M to $343.86M.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.